Factors impacting corneal epithelial barrier function against Pseudomonas aeruginosa traversal

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 3, 2011, Pages 1368-1377

  Alarcon, Irania ^a   Tam, Connie ^b   Mun, James J ^a   le Due, Jeffrey ^a,b   Evans, David J ^b,c   Fleiszig, Suzanne M J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TOURO UNIVERSITY CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; EGTAZIC ACID; GREEN FLUORESCENT PROTEIN; SURFACTANT PROTEIN D;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BACTERIUM ADHERENCE; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEAL EPITHELIAL BARRIER; EX VIVO STUDY; FLUORESCENCE HISTOCHEMISTRY; FLUORESCENCE IMAGING; IN VITRO STUDY; INOCULATION; LACRIMAL FLUID; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STROMA; TIGHT JUNCTION;

ANIMALS; BACTERIAL ADHESION; BASEMENT MEMBRANE; COLONY COUNT, MICROBIAL; CORNEAL ULCER; EGTAZIC ACID; EPITHELIUM, CORNEAL; EXTRACELLULAR MATRIX PROTEINS; EYE INFECTIONS, BACTERIAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FLUOROPHOTOMETRY; GREEN FLUORESCENT PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; TIGHT JUNCTIONS;

EID: 79955930098     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6125     Document Type: Article

References (48)

1. Cheng KH, Leung SL, Hoekman HW, et al. Incidence of contactlens- associated microbial keratitis and its related morbidity. Lancet. 1999;354:181-185.
2. Cruciani F, Cuozzo G, Di Pillo S, Cavallaro M. Predisposing factors, clinical and microbiological aspects of bacterial keratitis: a clinical study. Clin Ther. 2009;160:207-210.
3. Stapleton F, Keay L, Edwards K, et al. The incidence of contact lens-related microbial keratitis in Australia. Ophthalmology. 2008; 115:1655-1662.
4. Mun JJ, Tam C, Kowbel D, et al. Clearance of Pseudomonas aeruginosa from a healthy ocular surface involves surfactant protein D and is compromised by bacterial elastase in a murine null-infection model. Infect Immun. 2009;77:2392-2398.
5. Hazlett LD. Corneal response to Pseudomonas aeruginosa infection. Prog Retin Eye Res. 2004;23:1-30.
6. O'Callaghan RJ, McCormick CC, Caballero AR, et al. Age-related differences in rabbits during experimental Staphylococcus aureus keratitis. Invest Ophthalmol Vis Sci. 2007;48:5125-5131.
7. Gerke JR, Magliocco MV. Experimental Pseudomonas aeruginosa infection of the mouse cornea. Infect Immun. 1971;3:209 -216.
8. Hazlett L, Rosen D, Berk RS. Experimental eye infections caused by Pseudomonas aeruginosa. Ophthalmic Res. 1976;8:311-318.
9. Kimura K, Teranishi S, Nishida T. Interleukin-1beta-induced disruption of barrier function in cultured human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2009;50:597-603.
10. Yi X, Wang Y, Yu FS. Corneal epithelial tight junctions and their response to lipopolysaccharide challenge. Invest Ophthalmol Vis Sci. 2000;41:4093-4100.
11. Alarcon I, Evans DJ, Fleiszig SM. The role of twitching motility in Pseudomonas aeruginosa exit from and translocation of corneal epithelial cells. Invest Ophthalmol Vis Sci. 2009;50:2237-2244.
12. Alarcon I, Kwan L, Yu C, Evans DJ, Fleiszig SM. Role of the corneal epithelial basement membrane in ocular defense against Pseudomonas aeruginosa. Infect Immun. 2009;77:3264-3271.
13. Kwong MS, Evans DJ, Ni M, Cowell BA, Fleiszig SM. Human tear fluid protects against Pseudomonas aeruginosa keratitis in a murine experimental model. Infect Immun. 2007;75:2325-2332.
14. Fleiszig SM, Kwong MS, Evans DJ. Modification of Pseudomonas aeruginosa interactions with corneal epithelial cells by human tear fluid. Infect Immun. 2003;71:3866-3874.
15. Sosnova-Netukova M, Kuchynka P, Forrester JV. The suprabasal layer of corneal epithelial cells represents the major barrier site to the passive movement of small molecules and trafficking leukocytes. Br J Ophthalmol. 2007;91:372-378.
16. Fleiszig SM, Evans DJ, Do N, et al. Epithelial cell polarity affects susceptibility to Pseudomonas aeruginosa invasion and cytotoxicity. Infect Immun. 1997;65:2861-2867.
17. Kierbel A, Gassama-Diagne A, Rocha C, et al. Pseudomonas aeruginosa exploits a PIP3-dependent pathway to transform apical into basolateral membrane. J Cell Biol. 2007;177:21-27.
18. Gipson IK, Argueso P. Role of mucins in the function of the corneal and conjunctival epithelia. Int Rev Cytol. 2003;231:1-49.
19. McDermott AM. The role of antimicrobial peptides at the ocular surface. Ophthalmic Res. 2009;41:60 -75.
20. Ni M, Evans DJ, Hawgood S, et al. Surfactant protein D is present in human tear fluid and the cornea and inhibits epithelial cell invasion by Pseudomonas aeruginosa. Infect Immun. 2005;73: 2147-2156.
21. McNamara NA, Andika R, Kwong M, Sack RA, Fleiszig SM. Interaction of Pseudomonas aeruginosa with human tear fluid components. Curr Eye Res. 2005;30:517-525.
22. Fleiszig SM, Zaidi TS, Ramphal R, Pier GB. Modulation of Pseudomonas aeruginosa adherence to the corneal surface by mucus. Infect Immun. 1994;62:1799-1804.
23. McNamara NA, Van R, Tuchin OS, Fleiszig SM. Ocular surface epithelia express mRNA for human beta defensin-2. Exp Eye Res. 1999;69:483-490.
24. Bloemberg GV, O'Toole GA, Lugtenberg BJ, Kolter R. Green fluorescent protein as a marker for Pseudomonas spp. Appl Environ Microbiol. 1997;63:4543-4551.
25. Jumblatt MM, Neufeld AH. Beta-adrenergic and serotonergic responsiveness of rabbit corneal epithelial cells in culture. Invest Ophthalmol Vis Sci. 1983;24:1139-1143.
26. Lee EJ, Cowell BA, Evans DJ, Fleiszig SM. Contribution of ExsAregulated factors to corneal infection by cytotoxic and invasive Pseudomonas aeruginosa in a murine scarification model. Invest Ophthalmol Vis Sci. 2003;44:3892-3898.
27. Lee EJ, Evans DJ, Fleiszig SM. Role of Pseudomonas aeruginosa ExsA in penetration through corneal epithelium in a novel in vivo model. Invest Ophthalmol Vis Sci. 2003;44:5220-5227.
28. Ni M, Tam C, Verma A, et al. Expression of surfactant protein D in human corneal epithelial cells is upregulated by Pseudomonas aeruginosa. FEMS Immunol Med Microbiol. 2008;54:177-184.
29. Kishore U, Greenhough TJ, Waters P, et al. Surfactant proteins SP-A and SP-D: structure, function and receptors. Mol Immunol. 2006; 43:1293-1315.
30. Hobden JA, Masinick SA, Barrett RP, Hazlett LD. Proinflammatory cytokine deficiency and pathogenesis of Pseudomonas aeruginosa keratitis in aged mice. Infect Immun. 1997;65:2754-2758.
31. McCormick CC, Hobden JA, Balzli CL, et al. Surfactant protein D in Pseudomonas aeruginosa keratitis. Ocul Immunol Inflamm. 2007;15:371-379.
32. Beisel KW, Hazlett LD, Berk RS. Dominant susceptibility effect on the murine corneal response to Pseudomonas aeruginosa. Proc Soc Exp Biol Med. 1983;172:488-491.
33. Chambers D, Scott F, Bangur R, et al. Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis. Eur Respir J. 2005;26:651-656.
34. Preston MJ, Fleiszig SM, Zaidi TS, et al. Rapid and sensitive method for evaluating Pseudomonas aeruginosa virulence factors during corneal infections in mice. Infect Immun. 1995;63:3497-3501.
35. Dumbleton K. Adverse events with silicone hydrogel continuous wear. Cont Lens Anterior Eye. 2002;25:137-146.
36. Holden BA, Stephenson A, Stretton S, et al. Superior epithelial arcuate lesions with soft contact lens wear. Optom Vis Sci. 2001; 78:9 -12.
37. Jalbert I, Sweeney DF, Holden BA. Epithelial split associated with wear of a silicone hydrogel contact lens. CLAO J. 2001;27:231- 233.
38. Tam C, Mun J, Evans DJ, Fleiszig SM. The impact of inoculation parameters on the pathogenesis of contact lens related infectious keratitis. Invest Ophthalmol Vis Sci. 2010;51:3100-3106.
39. Masinick SA, Montgomery CP, Montgomery PC, Hazlett LD. Secretory IgA inhibits Pseudomonas aeruginosa binding to cornea and protects against keratitis. Invest Ophthalmol Vis Sci. 1997;38:910-918.
40. Sokol JL, Masur SK, Asbell PA, Wolosin JM. Layer-by-layer desquamation of corneal epithelium and maturation of tear-facing membranes. Invest Ophthalmol Vis Sci. 1990;31:294-304.
41. Wu H, Kuzmenko A, Wan S, et al. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest. 2003;111:1589-1602.
42. Hossain Z, Hirata T. Molecular mechanism of intestinal permeability: interaction at tight junctions. Mol Biosyst. 2008;4:1181-1185.
43. Fleiszig SM, Vallas V, Jun CH, et al. Susceptibility of epithelial cells to Pseudomonas aeruginosa invasion and cytotoxicity is upregulated by hepatocyte growth factor. Infect Immun. 1998;66:3443-3446.
44. Fleiszig SM, Zaidi TS, Fletcher EL, Preston MJ, Pier GB. Pseudomonas aeruginosa invades corneal epithelial cells during experimental infection. Infect Immun. 1994;62:3485-3493.
45. Soong G, Parker D, Magargee M, Prince AS. The type III toxins of Pseudomonas aeruginosa disrupt epithelial barrier function. J Bacteriol. 2008;190:2814-2821.
46. Hill MW. Influence of age on the morphology and transit time of murine stratified squamous epithelia. Arch Oral Biol. 1988;33: 221-229.
47. Fredj-Reygrobellet D, Hristova D, Balas D, Senegas-Balas F. Immunohistological localization of regenerating protein in ocular structures. Ophthalmic Res. 1996;28:130-136.
48. Kuroki Y, Takahashi M, Nishitani C. Pulmonary collectins in innate immunity of the lung. Cell Microbiol. 2007;9:1871-1879.